Apeiron Partners LLC is a boutique investment bank focused exclusively on the life sciences. We work closely with our clients to create and implement strategies that maximize corporate value through the creative structuring of spin-outs, other NewCos, financings and strategic alliances. Since its founding in 1995, Apeiron Partners has a strong track record of success in the life science sector, having worked on over 40 assignments. As a result, Apeiron has designed and negotiated a wide variety of transactions, including several spin-outs, a particular area of focus for the firm. With an extensive relationship network in all three major life science markets of North America, Europe and Japan and in the emerging markets as well, we enable our clients to pursue NewCo formations, partnering, M & A and investment opportunities worldwide.